Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 牙醫專業學院
  4. 臨床牙醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83428
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor郭彥彬(Yen-Ping Kuo),王振穎(Chen-Ying Wang)
dc.contributor.authorYun-An Linen
dc.contributor.author林芸安zh_TW
dc.date.accessioned2023-03-19T21:07:22Z-
dc.date.copyright2022-10-14
dc.date.issued2022
dc.date.submitted2022-09-17
dc.identifier.citation1.Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA, Genco RJ. Periodontitis in US Adults: National Health and Nutrition Examination Survey 2009-2014. J Am Dent Assoc 2018;149:576-588 e576. 2.Yu HC, Su NY, Huang JY, Lee SS, Chang YC. Trends in the prevalence of periodontitis in Taiwan from 1997 to 2013: A nationwide population-based retrospective study. Medicine (Baltimore) 2017;96:e8585. 3.Lai H, Su CW, Yen AM, et al. A prediction model for periodontal disease: modelling and validation from a National Survey of 4061 Taiwanese adults. J Clin Periodontol 2015;42:413-421. 4.Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. 5.Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 2018;45 Suppl 20:S162-S170. 6.Loe H, Theilade E, Jensen SB. Experimental Gingivitis in Man. J Periodontol 1965;36:177-187. 7.Seymour GJ. Importance of the host response in the periodontium. J Clin Periodontol 1991;18:421-426. 8.Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144. 9.Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-187. 10.Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249. 11.Newman MG TH, Klokkevold PR, Carranza FA. Newman and Carranza’s Clinical Periodontology 13th edition; 2018. 12.Berglundh T GW, Lang NP, Sanz M. Lindhe’s Clinical Periodontology and Implant Dentistry 7th edition; 2021. 13.Liu Y, Zhao R, Reda B, Yang W, Hannig M, Qu B. Profiling of cytokines, chemokines and growth factors in saliva and gingival crevicular fluid. Cytokine 2021;142:155504. 14.Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000 2016;70:53-64. 15.Ghallab NA. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: Review of the current evidence. Arch Oral Biol 2018;87:115-124. 16.Kowashi Y, Jaccard F, Cimasoni G. Sulcular polymorphonuclear leucocytes and gingival exudate during experimental gingivitis in man. J Periodontal Res 1980;15:151-158. 17.Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000 2005;39:53-72. 18.Costa FO, Cortelli SC, Silva TA, et al. Cytokine levels in crevicular fluid associated with compliance during periodontal maintenance therapy. Clin Oral Investig 2019;23:3517-3526. 19.Stadler AF, Angst PD, Arce RM, Gomes SC, Oppermann RV, Susin C. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. J Clin Periodontol 2016;43:727-745. 20.Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520. 21.Turer CC, Durmus D, Balli U, Guven B. Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor-A, and Tumor Necrosis Factor-Alpha Levels. J Periodontol 2017;88:493-501. 22.Sorsa T, Gursoy UK, Nwhator S, et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000 2016;70:142-163. 23.Zhang F, Liu E, Radaic A, et al. Diagnostic potential and future directions of matrix metalloproteinases as biomarkers in gingival crevicular fluid of oral and systemic diseases. Int J Biol Macromol 2021;188:180-196. 24.Nyman S, Lindhe J. A longitudinal study of combined periodontal and prosthetic treatment of patients with advanced periodontal disease. J Periodontol 1979;50:163-169. 25.Needleman I, Nibali L, Di Iorio A. Professional mechanical plaque removal for prevention of periodontal diseases in adults--systematic review update. J Clin Periodontol 2015;42 Suppl 16:S12-35. 26.Suvan J, Leira Y, Moreno Sancho FM, Graziani F, Derks J, Tomasi C. Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol 2020;47 Suppl 22:155-175. 27.Zhang X, Hu Z, Zhu X, Li W, Chen J. Treating periodontitis-a systematic review and meta-analysis comparing ultrasonic and manual subgingival scaling at different probing pocket depths. BMC Oral Health 2020;20:176. 28.Axelsson P, Lindhe J. The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 1981;8:281-294. 29.Magnusson I, Lindhe J, Yoneyama T, Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J Clin Periodontol 1984;11:193-207. 30.Tonetti MS, Muller-Campanile V, Lang NP. Changes in the prevalence of residual pockets and tooth loss in treated periodontal patients during a supportive maintenance care program. J Clin Periodontol 1998;25:1008-1016. 31.Jenkins WM, Said SH, Radvar M, Kinane DF. Effect of subgingival scaling during supportive therapy. J Clin Periodontol 2000;27:590-596. 32.Hokari T, Morozumi T, Komatsu Y, et al. Effects of Antimicrobial Photodynamic Therapy and Local Administration of Minocycline on Clinical, Microbiological, and Inflammatory Markers of Periodontal Pockets: A Pilot Study. Int J Dent 2018;2018:1748584. 33.Bogren A, Teles RP, Torresyap G, Haffajee AD, Socransky SS, Wennstrom JL. Locally delivered doxycycline during supportive periodontal therapy: a 3-year study. J Periodontol 2008;79:827-835. 34.Tonetti MS, Lang NP, Cortellini P, et al. Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent periodontitis but acceptable oral hygiene during supportive periodontal therapy. J Clin Periodontol 2012;39:475-482. 35.Salvi GE, Mombelli A, Mayfield L, et al. Local antimicrobial therapy after initial periodontal treatment. J Clin Periodontol 2002;29:540-550. 36.Newman MG, Kornman KS, Doherty FM. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994;65:685-691. 37.Wong MY, Lu CL, Liu CM, Hou LT, Chang WK. Clinical response of localized recurrent periodontitis treated with scaling, root planing, and tetracycline fiber. J Formos Med Assoc 1998;97:490-497. 38.Radvar M, Pourtaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J Periodontol 1996;67:860-865. 39.Kinane DF, Radvar M. A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets. J Periodontol 1999;70:1-7. 40.Rudhart A, Purucker P, Kage A, Hopfenmuller W, Bernimoulin JP. Local metronidazole application in maintenance patients. Clinical and microbiological evaluation. J Periodontol 1998;69:1148-1154. 41.Leiknes T, Leknes KN, Boe OE, Skavland RJ, Lie T. Topical use of a metronidazole gel in the treatment of sites with symptoms of recurring chronic inflammation. J Periodontol 2007;78:1538-1544. 42.Chondros P, Nikolidakis D, Christodoulides N, Rossler R, Gutknecht N, Sculean A. Photodynamic therapy as adjunct to non-surgical periodontal treatment in patients on periodontal maintenance: a randomized controlled clinical trial. Lasers Med Sci 2009;24:681-688. 43.Lulic M, Leiggener Gorog I, Salvi GE, Ramseier CA, Mattheos N, Lang NP. One-year outcomes of repeated adjunctive photodynamic therapy during periodontal maintenance: a proof-of-principle randomized-controlled clinical trial. J Clin Periodontol 2009;36:661-666. 44.Campos GN, Pimentel SP, Ribeiro FV, et al. The adjunctive effect of photodynamic therapy for residual pockets in single-rooted teeth: a randomized controlled clinical trial. Lasers Med Sci 2013;28:317-324. 45.Queiroz AC, Suaid FA, de Andrade PF, et al. Adjunctive effect of antimicrobial photodynamic therapy to nonsurgical periodontal treatment in smokers: a randomized clinical trial. Lasers Med Sci 2015;30:617-625. 46.Correa MG, Oliveira DH, Saraceni CH, et al. Short-term microbiological effects of photodynamic therapy in non-surgical periodontal treatment of residual pockets: A split-mouth RCT. Lasers Surg Med 2016;48:944-950. 47.Muller Campanile VS, Giannopoulou C, Campanile G, Cancela JA, Mombelli A. Single or repeated antimicrobial photodynamic therapy as adjunct to ultrasonic debridement in residual periodontal pockets: clinical, microbiological, and local biological effects. Lasers Med Sci 2015;30:27-34. 48.da Cruz Andrade PV, Euzebio Alves VT, de Carvalho VF, et al. Photodynamic therapy decrease immune-inflammatory mediators levels during periodontal maintenance. Lasers Med Sci 2017;32:9-17. 49.Xue D, Zhao Y. Clinical effectiveness of adjunctive antimicrobial photodynamic therapy for residual pockets during supportive periodontal therapy: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther 2017;17:127-133. 50.Goh EX, Tan KS, Chan YH, Lim LP. Effects of root debridement and adjunctive photodynamic therapy in residual pockets of patients on supportive periodontal therapy: A randomized split-mouth trial. Photodiagnosis Photodyn Ther 2017;18:342-348. 51.Giannopoulou C, Cappuyns I, Cancela J, Cionca N, Mombelli A. Effect of photodynamic therapy, diode laser, and deep scaling on cytokine and acute-phase protein levels in gingival crevicular fluid of residual periodontal pockets. J Periodontol 2012;83:1018-1027. 52.Wang CY, Yang YH, Li H, et al. Adjunctive local treatments for patients with residual pockets during supportive periodontal care: A systematic review and network meta-analysis. J Clin Periodontol 2020;47:1496-1510. 53.Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45:572-576. 54.Takasaki AA, Aoki A, Mizutani K, et al. Application of antimicrobial photodynamic therapy in periodontal and peri-implant diseases. Periodontol 2000 2009;51:109-140. 55.Wilson M, Dobson J, Sarkar S. Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol 1993;8:182-187. 56.Sarkar S, Wilson M. Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodontal Res 1993;28:204-210. 57.Grzech-Lesniak K, Gaspirc B, Sculean A. Clinical and microbiological effects of multiple applications of antibacterial photodynamic therapy in periodontal maintenance patients. A randomized controlled clinical study. Photodiagnosis Photodyn Ther 2019;27:44-50. 58.Ruhling A, Fanghanel J, Houshmand M, et al. Photodynamic therapy of persistent pockets in maintenance patients-a clinical study. Clin Oral Investig 2010;14:637-644. 59.Joshi D, Garg T, Goyal AK, Rath G. Advanced drug delivery approaches against periodontitis. Drug Deliv 2016;23:363-377. 60.Satomi A UR, Noguchi T, Ishikawa I, Tamaru H, Kitamura M. Minocycline HCl concentration in periodontal pockets after administration of LS-007. J Jap Assoc Periodontol 1987;29:937-943. 61.van Steenberghe D, Rosling B, Soder PO, et al. A 15-month evaluation of the effects of repeated subgingival minocycline in chronic adult periodontitis. J Periodontol 1999;70:657-667. 62.Miyazawa H, Nakajima T, Horimizu M, et al. Impact of Local Drug Delivery of Minocycline on the Subgingival Microbiota during Supportive Periodontal Therapy: A Randomized Controlled Pilot Study. Dent J (Basel) 2020;8. 63.McColl E, Patel K, Dahlen G, et al. Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study. J Clin Periodontol 2006;33:141-150. 64.Christodoulides N, Nikolidakis D, Chondros P, et al. Photodynamic therapy as an adjunct to non-surgical periodontal treatment: a randomized, controlled clinical trial. J Periodontol 2008;79:1638-1644. 65.Meinberg TA, Barnes CM, Dunning DG, Reinhardt RA. Comparison of conventional periodontal maintenance versus scaling and root planing with subgingival minocycline. J Periodontol 2002;73:167-172.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83428-
dc.description.abstract牙周維護性治療是牙周治療中重要一環,主要在預防牙周疾病復發,目前非手術治療 (洗牙及牙根整平術) 為其最主要之治療方式,但效果會因個體之疾病易感性、是否有深度破壞的牙周囊袋、牙根解剖構造或是細菌的再增生而受影響。因此,相關的輔助治療陸續被提出作為在牙周維護期治療殘餘囊袋的方法。本研究旨在觀察輔助性抗菌光動力治療或局部投予米諾環素凝膠相較於傳統洗牙及牙根整平術在牙周維護期治療殘餘囊袋之臨床療效。 本隨機控制臨床試驗納入58顆牙齒(來自34位病患),隨機分派至三組,分別為單純進行洗牙及牙根整平術 (組別A)、洗牙及牙根整平術加上光動力治療 (組別B)、洗牙及牙根整平術加上局部投予米諾環素凝膠 (組別C),連續治療兩週。第一次治療時,每組先進行洗牙及牙根整平,其中兩組額外分別加入光動力治療和米諾環素凝膠。第二次治療時,每組皆先進行全口洗牙,接下來,單純洗牙及牙根整平之組別只使用生理食鹽水沖洗以作為安慰劑,另兩組則如同第一次治療,再次分別使用光動力治療和米諾環素凝膠。並於治療前、治療後三個月、六個月及十二個月搜集牙齦溝液以進行發炎細胞激素分析(白介素-1、白介素-8、基質金屬蛋白?-8),以及紀錄臨床檢查數值(探測流血、牙周囊袋深度、牙周附連數值)。在一年期間每三個月回診時,皆進行全口洗牙及口腔衛教。 總共55顆牙齒完成試驗。在治療後的三個月追蹤可觀察到,組別C有較他組明顯的探測流血減少、牙周囊袋深度降低以及牙周附連增加。組別A、B、C在三個月之牙周囊袋降低量分別為1.12 ± 0.70mm、1.00 ± 0.91mm及1.38 ± 1.36m ; 牙周附連增加量分別為0.65 ± 0.93mm、0.72 ± 1.36mm及1.38 ± 1.36mm。在一年的追蹤結果中,三組臨床檢查數值皆有改善但無統計顯著差異,經由廣義估計方程式(generalized estimating equation, GEE)檢定後,組別B、C在探測流血、牙周囊袋深度降低之改善較組別A多。在發炎細胞激素表現部分,相較於治療前,三組皆顯著下降,而組別C之細胞激素表現顯著低於組別A。一年追蹤時之白介素-1、白介素-8及基質金屬蛋白?-8於組別A、B、C為0.0173 ± 0.0119pg、0.0079 ± 0.0068pg 及0.0075 ± 0.0064pg ; 0.1236 ± 0.0745pg、0.0815 ± 0.0748pg及0.0587 ± 0.0535pg ; 0.1932 ± 0.1898ng、0.0938 ± 0.0830pg及0.0721 ± 0.0743ng。 基於上述結果,可證實三種治療方式皆能有效改善牙周維持期之殘餘囊袋,但輔助性抗菌光動力治療及輔助性局部投予米諾環素凝膠對於降低牙周囊袋及產生牙周附連增加無法提供顯著額外臨床效果。另外可觀察到,輔助性局部給予米諾環素凝膠在三個月內有較明顯之臨床數值的改善和發炎細胞激素的下降。zh_TW
dc.description.abstractBackground: Supportive periodontal therapy (SPT) is an important maintenance phase to prevent the recurrence of disease progression. Professional scaling and root planning (Sc/RP) in SPT provides periodontal stability and improvement. However, residual pockets still exist during the SPT, especially in the patients with susceptible to periodontal disease, the sites with initial deep probing depth (PD), or anatomical variations, which make the complete removal of calculus difficult. In addition, microbial repopulation may also be a risk of disease recurrence. Therefore, several methods have been introduced as adjunctives to Sc/RP in treating residual pockets in SPT. This study aimed to conduct a randomized controlled clinical trial to investigate the treatment effect of Sc/RP-alone, Sc/RP combined with photodynamic therapy (PDT), and Sc/RP combined with locally administrated minocycline gel on treating residual pockets during SPT. Materials and Methods: Fifty-eight teeth recruited from thirty-four patients with residual pockets during SPT were randomly divided into three groups (Group A: Sc/RP-alone, Group B: Sc/RP + PDT, Group C: Sc/RP + minocycline gel). Sc/RP was performed in all groups over the target sites in the first week. Then, the photosensitizer (methylene blue) was applied and activated by the diode laser in Group B. Minocycline gel was locally delivered in Group C. In the second week, full mouth scaling was performed in all groups. Then, subgingival irrigation with normal saline (placebo) was performed in Group A. In Group B and Group C, PDT and minocycline gel were conducted again. Clinical parameters, including bleeding on probing (BOP), PD, and clinical attachment level (CAL) and gingival crevicular fluid (GCF) sampling for cytokine evaluation (IL-1??, IL-8, and MMP-8) were collected at different timepoints (baseline, post-treatment three months, six months, and twelve months). Full mouth scaling and oral hygiene instruction (OHI) were performed every three months for a year. Results: A total of 55 teeth were completed in the trial. The clinical status of the three groups was similar at baseline. Three months after treatments, better outcome of PD reduction and CAL gain in Group C was noticed. The PD reduction in Group A, Group B, and Group C at three-month follow-up were 1.12 ± 0.70mm, 1.00 ± 0.91mm, and 1.38 ± 1.36mm. Attachment gain were 0.65 ± 0.93mm, 0.72 ± 1.36mm, and 1.38 ± 1.36mm. In the one-year follow-up, clinical parameters were improved in all groups. Although there was no significant difference between groups, Group B and C had better improvement in PD and CAL than Group A confirmed by generalized estimating equations (GEE). Besides, IL-1??, IL-8, and MMP-8 were reduced in all groups after treatment and were significantly higher in Group A than in Group C at one-year follow-up. The IL-1??, IL-8, and MMP-8 in Group A, Group B and Group C at one-year follow-up were 0.0173 ± 0.0119pg, 0.0079 ± 0.0068pg and 0.0075 ± 0.0064pg, 0.1236 ± 0.0745pg, 0.0815 ± 0.0748pg, and 0.0587 ± 0.0535pg, 0.1932 ± 0.1898 ng, 0.0938 ± 0.0830pg and 0.0721 ± 0.0743ng. Conclusions: All treatments were effective in treating residual pockets during SPT. However, there was no significant difference between groups in clinical parameters, indicating that the adjunctive treatments of locally delivered minocycline gel or PDT on treating residual pockets during SPT did not offer benefits in terms of PD reduction and attachment gain, although both treatments reduced the periodontal inflammatory mediators within one year. Minocycline gel + Sc/RP tended to have a more short-term (three months) effectiveness than PDT + Sc/RP in the improvement of clinical parameters and the reduction of cytokines expression.en
dc.description.provenanceMade available in DSpace on 2023-03-19T21:07:22Z (GMT). No. of bitstreams: 1
U0001-1409202202095300.pdf: 6662551 bytes, checksum: 9991bf7e06a9949b85498f8920b3a270 (MD5)
Previous issue date: 2022
en
dc.description.tableofcontentsContents 誌謝…………………………………………………………………………………………………………………………………………………………………………………………………………I 中文摘要……………………………………………………………………………………………………………………………………………………………………………………………II Abstract…………………………………………………………………………………………………………………………………………………………………………………………IV Contents………………………………………………………………………………………………………………………………………………………………………………………VII List of figures…………………………………………………………………………………………………………………………………………………………………………X List of tables…………………………………………………………………………………………………………………………………………………………………………XI Chapter 1 Introduction………………………………………………………………………………………………………………………………………………………1 1-1. Periodontitis…………………………………………………………………………………………………………………………………………………………………1 1-1-1 Pathogenesis and progression of periodontitis…………………………………………………………………………2 1-1-2 Inflammatory mediators associated with periodontitis………………………………………………………4 1-1-3 Measurement of periodontitis………………………………………………………………………………………………………………………6 1-1-4 Gingival crevicular fluid as a source of biomarkers for periodontitis…………7 1-2. Treatment of periodontitis………………………………………………………………………………………………………………………………9 1-2-1 Supportive periodontal therapy………………………………………………………………………………………………………………10 1-2-2 Photodynamic therapy…………………………………………………………………………………………………………………………………………12 1-2-3 Locally delivered antibiotics…………………………………………………………………………………………………………………14 Chapter 2 Aim……………………………………………………………………………………………………………………………………………………………………………16 Chapter 3 Materials and methods……………………………………………………………………………………………………………………………17 3-1. Hypothesis………………………………………………………………………………………………………………………………………………………………………18 3-2. Study subjects……………………………………………………………………………………………………………………………………………………………19 3-2-1 Sample size…………………………………………………………………………………………………………………………………………………………………19 3-2-2 Inclusion criteria………………………………………………………………………………………………………………………………………………20 3-2-3 Exclusion criteria………………………………………………………………………………………………………………………………………………20 3-3. Equipment…………………………………………………………………………………………………………………………………………………………………………21 3-3-1 Constant pressure probe (Gram Probe#2, YDM, Higashi Matsuyama, Japan)………21 3-3-2 Helbo? photodynamic systemic (bredent medical, Germany)……………………………………………21 3-4. Experimental procedures and methods……………………………………………………………………………………………………22 3-4-1 Trial process……………………………………………………………………………………………………………………………………………………………22 3-4-2 Records of clinical parameters………………………………………………………………………………………………………………24 3-4-3 Sampling of gingival crevicular fluid……………………………………………………………………………………………24 3-4-4 Cytokine analysis…………………………………………………………………………………………………………………………………………………25 3-4-5 Statistical analysis…………………………………………………………………………………………………………………………………………26 Chapter 4 Results…………………………………………………………………………………………………………………………………………………………………27 4-1. Baseline characteristic……………………………………………………………………………………………………………………………………28 4-2. Clinical parameters changes…………………………………………………………………………………………………………………………29 4-2-1 PI score and BOP percentage………………………………………………………………………………………………………………………29 4-2-2 Probing depth and clinical attachment level……………………………………………………………………………30 4-2-3 Probing depth reduction and attachment gain……………………………………………………………………………32 4-3. Cytokines…………………………………………………………………………………………………………………………………………………………………………34 4-3-1 Expression of cytokines…………………………………………………………………………………………………………………………………34 4-3-2. Change of cytokines expression……………………………………………………………………………………………………………37 Chapter 5 Discussion…………………………………………………………………………………………………………………………………………………………39 5-1. Study design…………………………………………………………………………………………………………………………………………………………………41 5-2. Clinical parameters………………………………………………………………………………………………………………………………………………42 5-3. Cytokines expression……………………………………………………………………………………………………………………………………………46 5-4. Treatments………………………………………………………………………………………………………………………………………………………………………48 5-5. Clinical recommendation……………………………………………………………………………………………………………………………………51 Chapter 6 Conclusions………………………………………………………………………………………………………………………………………………………52 Appendix…………………………………………………………………………………………………………………………………………………………………………………………53 References……………………………………………………………………………………………………………………………………………………………………………………73 List of figures Fig 1. Pathogenesis of periodontitis………………………………………………………………………………………………………………53 Fig 2. Constant pressure probe………………………………………………………………………………………………………………………………54 Fig 3. Helbo? TheraLite Laser…………………………………………………………………………………………………………………………………55 Fig 4. The descriptive detail of the Helbo? TheraLite Laser from the manufacturer………………………………………………………………………………………………………………………………………………………………………………55 Fig 5. Trial process and randomization…………………………………………………………………………………………………………56 Fig 6. Group B (Test group, Sc/RP combined PDT)…………………………………………………………………………………57 Fig 7. Group C (Test group, Sc/RP combined local delivery of minocycline, Periocline?)………………………………………………………………………………………………………………………………………………………………………………57 Fig 8. Paperstrip…………………………………………………………………………………………………………………………………………………………………58 Fig 9. Periotron 8000, Oraflow Inc., New York, USA. ……………………………………………………………………58 Fig 10. Screening process of the subjects…………………………………………………………………………………………………59 Fig 11. Clinical parameters………………………………………………………………………………………………………………………………………60 Fig 12. Change of clinical parameters……………………………………………………………………………………………………………62 Fig 13. Cytokines expression……………………………………………………………………………………………………………………………………64 Fig 14. Change of cytokines expression…………………………………………………………………………………………………………66 List of tables Table 1. Baseline characteristic of clinical parameters……………………………………………………………68 Table 2. Clinical parameters at different time points…………………………………………………………………69 Table 3. Changes in clinical parameters………………………………………………………………………………………………………70 Table 4. Cytokines expression at different time points………………………………………………………………71 Table 5. Changes in cytokines expression……………………………………………………………………………………………………72
dc.language.isoen
dc.subject輔助性治療zh_TW
dc.subject牙根整平術zh_TW
dc.subject殘餘囊袋zh_TW
dc.subject米諾環素zh_TW
dc.subject光動力治療zh_TW
dc.subject牙周維護性治療zh_TW
dc.subjectPhotodynamic therapyen
dc.subjectAdjunctive therapyen
dc.subjectResidual pocketen
dc.subjectMinocyclineen
dc.subjectSupportive periodontal therapyen
dc.title牙周維護性治療期使用局部抗生素或光動力治療於殘餘囊袋之輔助成效:隨機控制臨床試驗zh_TW
dc.titleAdjunctive Effects of Locally Delivered Antibiotics or Photodynamic Therapy in Residual Pockets on Supportive Periodontal Therapy: A Randomized Controlled Clinical Trialen
dc.typeThesis
dc.date.schoolyear110-2
dc.description.degree碩士
dc.contributor.oralexamcommittee杜裕康(Yu-Kang Tu),張晉豪(Chin-Hao Chang),陳容慈(Jung-Tsu Chen)
dc.subject.keyword牙周維護性治療,殘餘囊袋,牙根整平術,輔助性治療,光動力治療,米諾環素,zh_TW
dc.subject.keywordSupportive periodontal therapy,Residual pocket,Adjunctive therapy,Photodynamic therapy,Minocycline,en
dc.relation.page78
dc.identifier.doi10.6342/NTU202203382
dc.rights.note未授權
dc.date.accepted2022-09-19
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept臨床牙醫學研究所zh_TW
顯示於系所單位:臨床牙醫學研究所

文件中的檔案:
檔案 大小格式 
U0001-1409202202095300.pdf
  未授權公開取用
6.51 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved